Mefenamic acid

FDA Drug Profile — Mefenamic acid

Mefenamic acid is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Mefenamic acid. Available dosage form: capsule.

Drug details

Generic Name
Mefenamic acid
Brand Names
Mefenamic acid
Application Number
ANDA090562
Sponsor
Micro Labs Limited
NDC Codes
2
Dosage Forms
CAPSULE
Routes
ORAL
Active Ingredients
MEFENAMIC ACID

Indications and Usage

1 INDICATIONS AND USAGE Mefenamic acid capsules are nonsteroidal anti-inflammatory drug indicated for: For management of mild to moderate pain in patient 14 years of age and older, when therapy will not exceed one week (7 days). ( 1.1 ) For treatment of primary dysmenorrhea. ( 1.2 ) 1.1 Mild to Moderate Pain Mefenamic acid capsules are indicated for management of mild to moderate pain in adults and pediatric patients 14 years of age and older, when therapy will not exceed one week (7 days). 1.2 Dysmenorrhea Mefenamic acid capsules are indicated for treatment of primary dysmenorrhea.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.